Provided by Tiger Trade Technology Pte. Ltd.

Immunoprecise Antibodies Ltd

2.07
0.0000
Volume:- -
Turnover:4.36M
Market Cap:95.54M
PE:-3.16
High:2.07
Open:2.07
Low:2.07
Close:2.07
52wk High:3.25
52wk Low:0.2700
Shares:46.15M
Float Shares:41.95M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6554
EPS(LYR):-0.6554
ROE:-101.96%
ROA:-14.81%
PB:5.54
PE(LYR):-3.16

Loading ...

Immunoprecise Antibodies Ltd expected to post a loss of 5 cents a share - Earnings Preview

Reuters
·
Jul 25, 2025

ImmunoPrecise Antibodies Unveils Breakthrough LENSai™ Technology for Early Detection of Anti-Drug-Antibody Risk

Reuters
·
Jul 24, 2025

ImmunoPrecise Antibodies Ltd. Welcomes Healthcare Data Expert Jeff Fried to Advisory Board

Reuters
·
Jul 21, 2025

Press Release: IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2025 on July 29, 2025

Dow Jones
·
Jul 16, 2025

ImmunoPrecise Antibodies Ltd. to Report Fourth Quarter and Full Fiscal Year 2025 Financial Results

Reuters
·
Jul 16, 2025

ImmunoPrecise Antibodies Ltd. Achieves Nasdaq Compliance, Meeting Minimum Bid Price Requirement

Reuters
·
Jul 14, 2025

ImmunoPrecise Antibodies Appoints Jon Lieber to Board of Directors, Strengthening Strategic Leadership

Reuters
·
Jul 07, 2025

BRIEF-Immunoprecise Validates Lensai Epitope Mapping Platform Across Broad Range Of Unseen Therapeutic Targets Beyond Training Data

Reuters
·
Jul 03, 2025

ImmunoPrecise's LENSai AI Platform Achieves Breakthrough in Mapping Unseen Antibody-Protein Complexes with High Precision

Reuters
·
Jul 03, 2025

ImmunoPrecise Antibodies Announces Breakthrough in Universal Dengue Vaccine Development with AI-Driven Safety and Efficacy Validation

Reuters
·
Jun 24, 2025

ImmunoPrecise Antibodies Ltd. Unveils Presentation Highlighting Advances in AI-Driven Drug Discovery and Biotherapeutics

Reuters
·
Jun 18, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Moderna, Cardinal Health, Adobe

Reuters
·
Jun 13, 2025

BUZZ-ImmunoPrecise jumps after AI peptides beat semaglutide in lab tests

Reuters
·
Jun 12, 2025

ImmunoPrecise Antibodies Announces Groundbreaking AI-Designed GLP-1 Peptides Surpassing Semaglutide in Receptor Activation Studies

Reuters
·
Jun 12, 2025

ImmunoPrecise Antibodies Ltd. Unveils AI-Driven Universal Dengue Vaccine Discovery, Paving Way for Broader Infectious Disease Solutions

Reuters
·
Jun 05, 2025

ImmunoPrecise Antibodies Ltd. Unveils Presentation on In Silico Strategies to Harness Rabbit-Derived Antibodies

Reuters
·
May 28, 2025

ImmunoPrecise Antibodies Partners with CORE IR to Boost Investor Engagement

Reuters
·
May 21, 2025

ImmunoPrecise Antibodies Ltd. to Present at Maxim Group's 2025 Virtual Tech Conference

Reuters
·
May 20, 2025